We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1951:HKEXEXEO Group, Inc. Analysis

Data as of 2026-06-14 - not real-time

¥2,700.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

EXEO Group is trading at ¥2,700, which sits about 1.9% above its DCF-derived fair value of ¥2,536, indicating a modest premium. The stock’s PE of 17.9x is well below the industry average of 30.6x, suggesting relative undervaluation on a fundamentals basis. A dividend yield of 2.96% with a 45% payout ratio and robust free cash flow (¥24.6 bn) points to sustainable income for shareholders. Revenue is expanding at a healthy 15% YoY rate, while operating margins hover around 8.7%, providing a stable earnings base. Balance‑sheet metrics show ample cash (¥41.7 bn) against debt, though the debt‑to‑equity ratio of ~39.6 warrants monitoring. Overall, the fundamentals paint a fairly attractive long‑run profile despite a slight price premium.
On the technical side, the RSI of 39 hints at near‑oversold conditions, yet the bearish MACD and a decreasing volume trend signal short‑term weakness. The stock’s beta of 0.16 and 30‑day volatility of 31% denote low market sensitivity but moderate price swings. With a neutral trend between the 20‑day SMA (¥2,800) and 200‑day SMA (¥2,548), price action is currently range‑bound. Given the modest upside potential, solid dividend, and stable cash generation, we view the stock as a hold in the near term, a modest buy for the medium horizon, and a strong buy for long‑term investors seeking income and exposure to Japan’s infrastructure upgrades.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal
  • Decreasing volume trend
  • RSI near oversold but not yet rebound

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE advantage versus industry
  • Sustainable dividend yield
  • Steady revenue growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong free cash flow generation
  • Long‑term infrastructure demand in Japan
  • Reasonable valuation relative to DCF

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin3.94%
P/E Ratio17.9
ROE9.20%
ROA4.88%
Debt/Equity39.58
P/B Ratio1.6
Op. Cash Flow¥33.2B
Free Cash Flow¥24.6B
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI39.3
Support¥2,645.00
Resistance¥2,916.00
MA 20¥2,799.80
MA 50¥2,825.44
MA 200¥2,548.26
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value¥2,535.78
Target Price¥2,750.00
Upside/Downside1.85%
GradeFair
TypeBlend
Dividend Yield2.96%

Risk Assessment

Beta0.16
Volatility31.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.